COVERSIN Uses, Dosage, Side Effects and more
COVERSIN is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).
| Trade Name | COVERSIN |
| Generic | Nomacopan |
| Nomacopan Other Names | COVERSIN, Nomacopan |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
